SCHEMBL14564366

SCHEMBL14564366

CCOC(=O)c1nc(-c2cccc(-c3ccccc3)c2)cs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
MAPT P10636 6/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
KDM4E B2RXH2 4/20 0.48
HPGD P15428 4/20 0.48
GAA P10253 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
PARP1 P09874 1/20 0.47
HSD17B10 Q99714 2/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
LMNA P02545 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694852 0.91 ALDH1A1 (0.56) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL6438482 0.89 NR1H4 (0.54) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL12876854 0.88 ATP4A (0.49) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL12942140 0.86 L3MBTL1 (0.61) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL3919689 0.86 SMN1; SMN2 (0.57) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL30194268 0.85 ALDH1A1 (0.57) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL6438695 0.85 L3MBTL1 (0.47) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL6855889 0.85 MEN1 (0.59) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL6437649 0.84 NR1H4 (0.45) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL30030772 0.84 NR1H4 (0.48) ALDH1A1MAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060584-A1 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers MERCK & CO., INC. 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060584-A1 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers TRPV1, TRPA1, TRPV3 ALDH1A1 937/4885MAPT 2044/4885MEN1 3910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.